Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…
ST. PAUL, Minn.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/microbiome?src=hash" target="_blank"gt;#microbiomelt;/agt;–CoreBiome, a microbiome discovery services provider and wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR),…
— EnClear Wins Massachusetts Life Sciences Center Award — CAMBRIDGE, Mass.–(BUSINESS WIRE)–EnClear Therapies, a biotechnology company developing device-based therapies for…
-FIERCE-21 and FIERCE-22 Phase 2 Trials in Metastatic Bladder Cancer- SAN LEANDRO, Calif.–(BUSINESS WIRE)–Rainier Therapeutics, Inc., a privately-held clinical stage…
— Peer-Reviewed Publication Details Next Steps for Access to Safe, Secure DNA Synthesis — SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience…
Building customer trust and loyalty through more effective engagement DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV) today announced…
–Award-winning startup selected to join state-of-the-art coworking facility– NEW YORK–(BUSINESS WIRE)–BioLabs@NYULangone today announced that MEND, a company developing nutritional interventions…
Said Barry Butler, “I believe the advantages offered by theEyesol® platform will bring significant benefits to glaucomapatients.”
Inclisiran’s unique profile, vast global market opportunity and long-dated exclusivity set the stage for potentially significant shareholder value creation Independent…
Increases First Quarter Revenues 14% to $5.9 Billion Posts First Quarter GAAP EPS of $1.04 and Non-GAAP EPS of $1.10…